If you’ve been following my writing, you know that one of my biggest interests is how to protect brain and vascular health in people with the APOE4 gene variant. APOE4 increases the risk of Alzheimer’s disease and heart disease, partly because it alters the way our bodies handle cholesterol and fats. Today, I want to shine a light on something that’s not yet mainstream but looks very promising:
Karin, I've been following the cyclodextrin research for about a year. Here's an interesting study that showed clyclodextrins reduced both intracellular cholesterol and accumulation of neutral lipids such as triacylglycerides for 4/4 carriers. https://pmc.ncbi.nlm.nih.gov/articles/PMC9870060/ Fortunately, my Lp(a) is normal so it’s not critical for me at this point but I'm definitely keeping an eye on this.
Karin, I've been following the cyclodextrin research for about a year. Here's an interesting study that showed clyclodextrins reduced both intracellular cholesterol and accumulation of neutral lipids such as triacylglycerides for 4/4 carriers. https://pmc.ncbi.nlm.nih.gov/articles/PMC9870060/ Fortunately, my Lp(a) is normal so it’s not critical for me at this point but I'm definitely keeping an eye on this.
Thanks for sharing this Karen!
Yes. I’m APOE4/4 with MCI and would be interested in trying it out
Dr Fred Fronstin
561 7164455
Fred, the only company I know who sells this product currently is https://atherocare.com/products/atherocare. Cyclarity is not on the market yet.